Archived at

Similar documents
Last 2-3 months of lactation

Milk Quality Management Protocol: Fresh Cows

Guideline on the conduct of efficacy studies for intramammary products for use in cattle

Assessment of the effect of homoeopathic nosodes in subclinical bovine mastitis

New York State Cattle Health Assurance Program Fact Sheet Udder Health Herd Goals

Comparison of different methods to validate a dataset with producer-recorded health events

Selective Dry Cow Therapy

AUTOMATIC MILKING SYSTEMS AND MASTITIS

MALLA HOVI & STEVE RODERICK, Veterinary Epidemiology and Economics Unit, University of Reading, PO Box 236, READING RG6 6AT

LOCAL TOLERANCE OF INTRAMAMMARY PREPARATIONS IN COWS

Using DHIA and bacteriology to investigate herd milk quality problems.

Mastitis in ewes: towards development of a prevention and treatment plan

How to Decrease the Use of Antibiotics in Udder Health Management

Strep. ag.-infected Dairy Cows

Controlling Contagious Mastitis

Case Study: Dairy farm reaps benefits from milk analysis technology

Mastitis: Background, Management and Control

Responsible Use of Antimicrobials in Dry Cow Strategies

The Bimeda Guide to Selective Dry Cow Therapy

Genetic and Genomic Evaluation of Mastitis Resistance in Canada

Selective Dry Cow Therapy

Key words: mastitis, dairy, fertility, animal reproduction

Milk quality & mastitis - troubleshooting, control program

Mastitis control in bred heifers: Use of dry cow therapy and teat sealant for curing existing intramammary infections and preventing new ones

2012 Indiana Regional Dairy Meetings. Purdue University College of Veterinary Medicine Dr. Jon Townsend Dairy Production Medicine

Influence of Management Techniques on the Levels of Mastitis in an Organic Dairy Herd Mastitis management in organic herd

MASTITIS CASE MANAGEMENT

Mastitis cows and immunization

, Pamela L. Ruegg

Development of a Breeding Value for Mastitis Based on SCS-Results

Minna Koivula & Esa Mäntysaari, MTT Agrifood Research Finland, Animal Production Research, Jokioinen, Finland

Veterinaria.com.pt 2009; Vol. 1 Nº 1: e13 (publicação inicial em Julho de 2008) Disponível em

The mastitis situation in Canada where do you stand?

Cepravin and Combination Dry Cow Therapy Trial Work

Somatic Cell Count as an Indicator of Subclinical Mastitis. Genetic Parameters and Correlations with Clinical Mastitis

A New Index for Mastitis Resistance

LOOKING FOR PROFITS IN MILK QUALITY

Premiums, Production and Pails of Discarded Milk How Much Money Does Mastitis Cost You? Pamela Ruegg, DVM, MPVM University of Wisconsin, Madison

Presented at Central Veterinary Conference, Kansas City, MO, August 2013; Copyright 2013, P.L Ruegg, all rights reserved

CLINICAL MASTITIS PERCEPTIONS OF KANSAS DAIRY PRODUCERS. J.R. Roberson 1

Guideline on the conduct of efficacy studies for intramammary products for use in cattle

Guideline on the conduct of efficacy studies for intramammary products for use in cattle

Quality Milk on Pasture Based Dairy Farms. Scott E. Poock, DVM University of Missouri Clinical Assistant Professor DABVP Beef and Dairy Cattle

International Journal of Science, Environment and Technology, Vol. 6, No 2, 2017,

Herd Navigator and mastitis management

Outline MILK QUALITY AND MASTITIS TREATMENTS ON ORGANIC 2/6/12

Mastitis MANAGING SOMATIC CELLS COUNTS IN. Somatic Cell Count Are Affected by. Somatic Cells are NOT Affected by:

Options for Handling Mastitis during Lactation in Modern Dairy Farms

Effect of omitting post-milking teat disinfection on the mastitis infection rate of dairy cows over a full lactation

Institut for Produktionsdyr og Heste

Milk Quality Evaluation Tools for Dairy Farmers

Prototheca Mastitis in Dairy Cows

Management traits. Teagasc, Moorepark, Ireland 2 ICBF

Walter M. Guterbock, DVM, MS Veterinary Medicine Teaching and Research Center University of California, Davis

ENVIRACOR J-5 aids in the control of clinical signs associated with Escherichia coli (E. coli) mastitis

Evaluation of intervention strategies for subclinical and clinical mastitis

Your clients need you to help them reach their full dairy potential.

Influence of Experimentally- induced clinical mastitis on Reproductive Performance of Dairy Cattle

Advanced Interherd Course

Nordic Cattle Genetic Evaluation a tool for practical breeding with red breeds

Using SCC to Evaluate Subclinical Mastitis Cows

Interpretation of Bulk Tank Milk Results

1/1/ K BEAT IT!

DeLaval Cell Counter ICC User Strategies Guide

Mastitis in non-bovine dairy species, companion animals and breastfeeding mothers. Chris Knight

Dairy/Milk Testing Report Detecting Elevated Levels of Bacteria in Milk-On-Site Direct- From-The-Cow Within Minutes as Indicator of Mastitis

University of Missouri Extension Using the California Mastitis Test

From science to practice improved udder health with the German project milchqplus

Dr. Michelle Arnold, DVM DABVP (Food Animal) Ruminant Extension Veterinarian University of Kentucky Veterinary Diagnostic Laboratory

Innovation in Mastitis Treatment

NEW ZEALAND DAIRY INDUSTRY AND COLOSTRUM

Section 2: KPI Results for the year ending 31/08/2017

Actions and Outcomes of Wisconsin Dairy Farms Completing Milk Quality Teams

Summary. Table 1. Estimated infection prevalence and losses in milk production associated with elevated bulk tank somatic cell counts.

Decide dry cow strategy - drying off dates, antibiotic Dry Cow and Internal Teat Sealant treatments?

Animal Health and You

Mastitis Reminders and Resources LAURA SIEGLE EXTENSION AGENT VIRGINIA COOPERATIVE EXTENSION AMELIA COUNTY

1 st EMP-meeting: European boom in AMS and new tools in mastitis prevention

Environmental and genetic effects on claw disorders in Finnish dairy cattle

A PRACTISING VETS APPROACH TO THE HIGH CELL COUNT HERD

TECHNICAL BULLETINMay 2014

New Developments in Mastitis Research

The use of on-farm culture systems for making treatment decisions

Association between teat skin colonization and intramammary infections with Staphylococcus aureus and Streptococcus agalactiae

DAIRY HERD HEALTH IN PRACTICE

Finnzymes Oy. PathoProof Mastitis PCR Assay. Real time PCR based mastitis testing in milk monitoring programs

Using Technology to Improve Calf Raising Sam Barringer, DVM Merck Animal Health

F-MC-2: Dealing with Streptococcus agalactiae Mastitis

Management factors associated with veterinary usage by organic and conventional dairy farms

Index for Mastitis Resistance and Use of BHBA for Evaluation of Health Traits in Canadian Holsteins

Proper Dry-Off Procedures to Prevent New Infections and Cure Existing Cases of Mastitis. Stephen C. Nickerson University of Georgia

Mastitis and On-Farm Milk Cultures - A Field Study - Part 1

Mastitis Prevention and Cure Rates in Heifers Treated with Spectramast Dry Cow Therapy and/or Orbeseal Dry Cow Teat Sealant

New Model. Digital Mastitis Detector. Reduce of risk at early stage

Animal Welfare Program of Chilean Dairy Consortiumsortiu. Danitza Abarzúa B. Animal welfare program coordinator

Analysis of the microbial population that most often causes mastitis in dairy cows

Interpretation and Use of Laboratory Culture Results and the Characteristics of Various Mastitis Pathogens

S. P. Oliver, R. A. Almeida, B. E. Gillespie, S. J. Ivey, H. Moorehead, P. Lunn, H. H. Dowlen, D. L. Johnson, and K. C. Lamar

Decision tree analysis of treatment strategies for mild and moderate cases of clinical mastitis occurring in early lactation

MASTITIS DNA SCREENING

Transcription:

Treatment of bovine sub-clinical mastitis with homeopathic remedies P. Klocke 1, S. Ivemeyer 1, F. Heil 1, M. Walkenhorst 1, C. Notz 1 Key words: dairy cattle, sub-clinical mastitis, homeopathy Abstract Considering the positive results of homeopathic therapy of bovine mastitis, the presented study should evaluate the effects of two standardized homeopathic methods in sub-clinical mastitis using a prospective randomized double-blind placebo control study design. A number of 124 dairy cows from 17 herds with increased somatic cell count were selected and randomly associated to 5 treatment groups. Two groups received a peroral therapy with (a) a homeopathic combination over 5 days and (b) a single treatment with a homeopathic nosode (Tuberculinum). To each treatment group a placebo control group was established with the same treatment frequency. A fifth group served as an untreated control. The bacteriological cure rate after 4 and 8 weeks was 28% and the total cure rate additionally regarding a normalized somatic cell count was 14% and 18%, respectively. There was no significant effect by the remedies at all. The cow somatic cell count over three months after treatment showed no significant difference in the five groups. Standardized homeopathic combinations and Tuberculinum nosodes are not able to control subclinical mastitis during lactation. If other factors like age and microbial agent are responsible for the success of homeopathy or if more individualized protocols provide better results has to be answered in further investigations. Introduction Mastitis is the most common health problem in Swiss organic dairy herds. The regulations and consumer presumptions claim a minimal chemo-therapeutic intake to control udder health although antibiotics are very effective under certain conditions. On the other hand there are existing problematic mastitis causing micro-organisms which are resistant to antibiotics. Thus, the preferred complementary treatment methods in organic dairy farms are an important research field for alternatives in conventional mastitis control, too. There are three areas of therapeutic mastitis control strategies, (a) therapy of acute clinical mastitis, (b) therapy of chronic and sub-clinical mastitis and (c) prophylaxis at drying off. Besides a huge potential of self-cure and physical methods like milking-out and cooling ointments, homeopathically supported treatment of acute mastitis could provide satisfying results (Klocke et al., 2004; Klocke et al., 2000; Merck et al., 1989). Dry-off therapy (prophylaxis) in conventional herds is commonly conducted by intra-mammary application of long-term antibiotics to (a) treat sub-clinical mastitis and (b) prevent for new infections during the critical dry time. Alternatives like teat sealants has been established as a hopeful concept to close the teat ends and prevent environmental microbial invasion (Woolford et al., 1998), but did not always lead to the required effects (Klocke et al., 2006). Homeopathy based dryoff concepts only provided satisfying results in the prevention against certain microorganisms (Klocke et al., 2006) or in combination with antibiotics (Klocke et al., 2000). Preventive effects by using so-called homeopathic nosodes produced by potentized 1 Research Institute of Organic Agriculture, CH-5070 Frick, Switzerland, E-mail peter.klocke@fibl.org, Internet www.fibl.org Archived at http://orgprints.org/10313/

microbial cultures or other pathologic secretions are very limited (Barlow et al., 2001; Fidelak et al., 2007). However, the treatment of sub-clinical mastitis during lactation is an uncommon concept because of the sub-sequent withdrawal time after antibiosis. Thus, the idea of using residual-free agents like homeopathics during lactation could be an acceptable method to avoid additional costs and provide an alternative to the discontenting period of rest between sub-clinical mastitis detection and dry-off. Although there is no evidence of effectiveness of these concepts (Egan, 1995), there is a huge gap of knowledge on this field. The prospect of a cheap additional mastitis control concept especially for organic farmers justifies further research about this. Consequently, in this presentation two common concepts should be evaluated in terms of their effects in case of sub-clinical mastitis on subsequent somatic cell count (cow level) and infection state (quarter level) hypothetically expecting a higher cure rate on quarter level in the verum groups compared to the other and a significant lower somatic cell count on cow level during the observation period of 3 months. Materials and methods From a national swiss udder health improvement project network a number of 17 recently recruited organic dairy herds with identified sub-clinical mastitis problems were chosen for the investigation. In these herd a total number of 150 cows were selected which matched the following criteria: (a) monthly recorded somatic cell count beyond 100 000 cells/ml for 3 subsequent times or continuing after calving, (b) no sensory aberrations of milk or udder tissue, (c) no acute or reconvalent udder or teat injuries. A number of 125 cows matched all these criteria. After cow selection a randomization of trial cows for each farm was conducted and the cows were classified in 5 treatment groups as shown in table 1. Tab. 1: Treatment group definition and treatment protocols Group Remedy and dilution Treatment protocol H Combination of Calcarea carbonica D30 & Phosphorus D15 & Pulsatilla pratensis D6 & Atropa Belladonna D6 & Lac vaccae D60 Peroral treatment of 10 globuli diluted in 5 ml tap water for 5 days N Nosode: Tuberculinum Koch C30 Peroral treatment of 10 globuli diluted im 5 ml tap water onetime C H Corresponding placebo to Group H Like in group H C N Corresponding placebo to group N Like in group N U Untreated control group - The group H was treated with remedies as recommended especially for bio-dyn farms (Spranger and Walkenhorst, 2006). Before treatment quarter milk samples for bacteriological and cell count investigations were taken and repeated approx. 4 (C1) and 8 (C2) weeks after treatment. The results of the quarter findings were categorized in (a) not suspicious quarters with no positive cultural findings and somatic cell count (SCC) below 100 000/ml, (b) cell count elevated quarters with no cultural findings and cell counts >100 000/ml and (c) subclinically infected quarters with > 100 000 SCC and cultural positive results. The basic laboratory results were compared to those of the control samples. The bacterial cure rate (BCR) was calculated as the number of quarters with no bacteriologic positive

results in the respective control investigation by all treated quarters, the total cure rate (TCR) represented the bacteriologically cured quarters with normal somatic cell counts <100.000/ml. The cure rate comparison was analysed by using a univariate logistic regression model with the independent variable treatment group with 5 levels. Milk records of monthly routine milk test data were documented over 3 months before (T-3 to T-1) and after (T1 to T3) treatment and the logarithmic transformed somatic cell counts (Linear Score) were compared to the mean of cell counts 3 months before treatment or from calving to treatment using ANOVA analysis. The general significance level was set to α=0.05. All data analysed by the statistic software package JMP (SAS institute). Results A total number of 124 cows entered the study. After laboratory investigation a number of 84 cows (149 quarters) were assessed as sub-clinically infected, all other cows showed only a cell count increase (n=31) or normal secretion (n=9). On cow level the bacteriological cure rate (10.7 and 4.8% in control investigation 1 and 2, resp.) and the total cure rate (2.4 and 4.8%, resp.) was poor in all treatment groups (see table 3) for both control investigations. There was no effect by the verum therapy on cow level at all. Quarters in the Nosode control group showed a significant higher Cure rate in the first control investigation compared to untreated control. Tab. 2: Data of quarter bacteriological cure rates (BCR) and total cure rates (TCR) in the control investigations C1 and C2. Parameters Treatment Group Total H N C H C N U # cows 25 24 24 26 25 124 # quarters 100 96 96 104 100 496 # subclinical infections 34 33 32 26 24 149 BCR C1 (4 wks) 35% a (n=12) 27% a (n=9) 16% a (n=5) 42% b (n=11) 17% a 28% (n=41) BCR C2 (8 wks) TCR C1 (4 wks) TCR C2 (8 wks) 41% a (n=14) 24% a 24% a 19% a (n=6) 3% a (n=1) 6% a (n=2) 31% a 31% b 19% a (n=5) 25% a (n=6) 4% a (n=1) 17% a Values with different superscripts a,b within one line are significantly different with p<0.05 compared to untreated control in the logistic regression 28% (n=42) 12% (n=18) 15% (n=23) As seen in Figure 1 there is no effect on the somatic cell count after treatment. All 5 groups showed a stabilizing effect compared to development of SCC in the three months before treatment.

Figure 1: Logarithmically transformed somatic cell counts of cows three months before and three months after treatment in the five treatment groups; standard deviations not shown due to clearness. Discussion & Conclusions In general there are no beneficial effects after the treatment with combined homeopathics and the tuberculinum nosode on sub-clinical mastitis. It has to be analysed if there are differences of treatment success depending on species or other factors like age and farm. It has to be analysed if classical homeopathic methods or other remedies are able to provide better results. On the other hand, taking into account the results of other studies, the prognosis of cure sub-clinical mastitis is poor. Anyway, the hypothesis of efficient treatment with the presented remedies has to be rejected. Acknowledgments The authors gratefully acknowledge funding from the European Community financial participation and the Swiss State Secretariat for Education and Research SER/SBV under the Sixth Framework Programme for Research, Technological Development and Demonstration Activities, for the Integrated Project QUALITYLOWINPUTFOOD, FP6-FOOD-CT-2003-506358. Disclaimer The views expressed in this publication are the sole responsibility of the author(s) and do not necessarily reflect the views of the European Commission. Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use which might be made of the information contained herein.

References Barlow, J., McCrory, L., Mulloy, E., Bahrawy, D., Woodard, S., Craft, L., Mourdough, P., Pankey, J.W. (2001): Evaluation of a Homeopathic Nosode for Mastitis Prevention. Proceedings of the 2nd International Symposium on Mastitis and Milk Quality 2001, 258-262. Egan, J. (1995): Evaluation of a homoeopathic treatment for subclinical mastitis. Veterinary Record 137, 48. Fidelak, C., Berke, M., Klocke, P., Spranger, J., Hamann, J., Heuwieser, W. (2007): Nosoden zum Trockenstellen - eine placebokontrollierte Blindstudie. In: Wissenschaftstagung, Hohenheim, 2007. Klocke, P., Fidelak, C., Garbe, S., Rothe, J., Paal, K., Spranger, J., Merck, C.C. (2004): Are homeopathics able to replace antibiotics in the therapy of bovine mastitis? A placebo controlled randomized double-blind trial. In: 23rd World Buiatrics Congress, Quebec, 2004, pp 56. Klocke, P., Garbe, S., Spranger, J., Merck, C.C. (2000): Homeopathic supported udder health control regarding cow associated factors in Brandenburg (D). In: 13th International IFOAM Scientific Conference, Basel, 2000b, pp 343. Klocke, P., Ivemeyer, S., Walkenhorst, M., Maeschli, A., Heil, F. (2006): Handling the dry-off problem in organic dairy herds by teat sealing or homeopathy compared to therapy omission. In: Organic Joint Congress, Odense (DK), May 30th to 31st, 2006. Merck, C., Sonnenwald, B., H., R. (1989): Untersuchung über den Einsatz homöopathischer Arzneimittel zur Behandlung akuter Mastitiden beim Rind. Berl. Münch. Tierarztl. Wochenschr. 102, 266-272. Spranger, J., Walkenhorst, M. (2006): Grundsätze der anthroposophischen Tiermedizin am Beispiel der hochleistenden Milchkuh. Zeitschrift für Ganzheitliche Tiermedizin 20, 137-141. Woolford, M.W., Williamson, J.H., Day, A.M., Copeman, P.J. (1998): The prophylactic effect of a teat sealer on bovine mastitis during the dry period and the following lactation. N Z Vet J 46, 12-19.